An update on malignant hyperthermia diagnostics and anaesthetic machine preparation for patients at risk in Africa

Abstract

The EMHG first published its protocol for an in vitro contracture test (IVCT) in 19841 and this has ever since formed the bedrock of clinical diagnosis and phenotyping. In 20152 the EMHG published the updated guidelines for investigation of malignant hyperthermia susceptibility. Evidently the rigour of the IVCT stood the test of time and was used in more than 10 000 individuals worldwide to define their MH risk, representing an example of preventative medicine and improved patient safety.

Metadata

Authors/Creators:	Brand, JC Hopkins, PM https://orcid.org/0000-0002-8127-1739
Copyright, Publisher and Additional Information:	(c) 2018 The Author(s) Open Access article distributed under the terms of the Creative Commons License [CC BY-NC-ND 4.0] http://creativecommons.org/licenses/by-nc-nd/4.0
Dates:	Published (online): 28 May 2018 Published: 6 June 2018
Institution:	The University of Leeds
Academic Units:	The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Inst of Biomed & Clin Sciences (LIBACS) (Leeds) > Trans Anaesthetics & Surgical Sciences (Leeds)
Depositing User:	Symplectic Publications
Date Deposited:	29 Jun 2018 07:57
Last Modified:	29 Jun 2018 07:57
Published Version:	http://www.sajaa.co.za/index.php/sajaa/article/vie...
Status:	Published
Publisher:	Taylor & Francis

CORE (COnnecting REpositories)

An update on malignant hyperthermia diagnostics and anaesthetic machine preparation for patients at risk in Africa

Abstract

Metadata

Download

Published Version

Export

Statistics